Welcome to Harborside Expert Perspectives

Andrew Kuykendall, MD, and Natasha L. Johnson, MSN, APRN, AOCNP®, both of Moffitt Cancer Center, discuss how they approach treatment in the clinic for patients with myelofibrosis, touching on risk stratification, splenomegaly, anemia, and disease symptoms. They also talk about historic treatment options for anemic patients, as well as the significance of prognostic models.